In November 2019, during the American Heart Association (AHA) 2019 Scientific Sessions, researchers presented this revolutionary trial that called the attention of all cardiologists. We had to wait until March to read the fine print; back then, a global pandemic such as the current one seemed out of a science-fiction tale. The world has changed<a href="https://solaci.org/en/2020/04/01/virtual-acc-2020-controversial-trial-ischemia-finally-in-nejm/" title="Read more" >...</a>
According to the TVT Registry, patients who undergo transcatheter aortic valve replacement (TAVR) with conscious sedation have better outcomes, including lower mortality rates. A minimalist strategy always (sooner or later) proves to be superior across our whole range of procedures, from a simple diagnostic study with local anesthesia and a 4-Fr transradial access, to a<a href="https://solaci.org/en/2020/03/25/virtual-acc-2020-conscious-sedation-in-tavr/" title="Read more" >...</a>
SOLACI’s commitment to the development of interventional cardiology in Latin America doubles down in 2020. Our institution is fostering a variety of events, programs, and activities to continue boosting our specialty in our region, a tradition we have never ceased to honor in the past 26 years. From February 28th to March 2nd, 2021, Hilton Buenos<a href="https://solaci.org/en/2020/03/19/2020-solaci-calendar-of-events-a-year-full-of-extraordinary-interventional-cardiology-events/" title="Read more" >...</a>
Long after AHA 2019 had presented observational studies showing adverse events associated to Impella, JAMA is finally publishing the official results including all charts and small print. The controversial analysis of the American registry had suggested worse outcomes with the intravascular microaxial left ventricular assist device Impella vs. the intra-aortic balloon pump in acute myocardial<a href="https://solaci.org/en/2020/03/06/impella-and-adverse-events/" title="Read more" >...</a>
We have the pleasure to announce the creation of SOLACI’s research department under the name “SOLACI Research”, aimed at fostering clinical research in the region by creating registries, developing local guidelines, core-lab, consultation and training sessions coordinated by SOLACI. All interventional cardiologists meeting our basic requirements willing to participate can join the research department as<a href="https://solaci.org/en/2020/03/05/solaci-research-solacis-innovative-research-area/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. One of the major challenges we interventional cardiologists still face is access management. Reduced device diameter and improved transcatheter closure, together with increased operator experience, have significantly reduced vascular complications. However, we shouldn’t lose sight of the secondary access, usually transfemoral, generally used in case of primary access site related<a href="https://solaci.org/en/2020/03/04/tavr-should-transradial-approach-be-the-second-access-site/" title="Read more" >...</a>
Clinical practice guidelines are usually tedious and, frankly, while a lot of people make an enormous effort to write them, they are ultimately read in full by just a few. These new European Guidelines on the Management of Lower Limb Acute Ischemia represent a special team effort, since they include physicians, cardiologists, surgeons, and interventionists,<a href="https://solaci.org/en/2020/02/07/new-european-guidelines-on-the-management-of-lower-limb-acute-ischemia/" title="Read more" >...</a>
After the “EXCEL scandal” at the end of last year, study investigators have been publishing explanations and sub-studies that were planned from the beginning, but which can still be interpreted as explanations. This sub-study states that revascularization was more common in the angioplasty arm, but only revascularizations performed on the target lesion, regardless of the<a href="https://solaci.org/en/2020/02/07/repeat-revascularization-is-not-benign-at-least-in-left-main-disease/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. In modern studies, carotid artery stenting (CAS) has been shown equal to surgery in terms of the composite end point of periprocedural stroke, death, acute myocardial infarction and late ipsilateral stroke. This was tested in different groups and by trained operators. In the CREST-2 Registry (C2R) 2141 patients were included,<a href="https://solaci.org/en/2020/01/27/crest-2-registry-carotid-pci-presents-low-rates-of-death-and-stroke/" title="Read more" >...</a>
ARGENTINIAN MAGAZINE OF INTERVENTIONAL CARDIOLOGISTS The Argentinian School of Interventional Cardiologists is a scientific society meant for all hemodynamics and interventional cardiology specialists in Argentina. It was created in 1985 with the support of the National Health Ministry to certify the Hemodynamics and General Angiology specialty. It is a medical society with a very active<a href="https://solaci.org/en/2020/01/13/publications-of-interest/" title="Read more" >...</a>